Board of Directors
Gordon Sato, PhD | Co-Founder & Chairman of the Board, A&G Pharmaceutical
Lars Hanan, MBA | Co-Founder and Managing Partner, BroadOak Capital Partners
Tom Hancock | Principal, New England Partners/Nexus Medical Partners Fund
SeungSuh “Stanley” Hong, PhD | President of Research & Development, Celltrion
Dr. Hong is Senior Vice President of of Business Development for Celltrion and an advisor to R&D. Prior to joining Celltrion, he led research and development at Samyang Genex Corp., with responsibility for plant cell culture and mammalian cell culture programs. Among the many products he has developed, Dr. Hong is credited with using plant cell culture to develop paclitaxel (Taxol®), a mitotic inhibitor used in cancer chemotherapy. Dr. Hong received a PhD in Enzymology and Biochemical Engineering from Seoul National University.
Jennie Mather, PhD | Senior Vice President, Stem Cell Research, MacroGenics
Ginette Serrero, PhD | Co-Founder and CEO
Seung Il-Shin, PhD | Founder, Celltrion